Reading this on a phone? Click here for the mobile version
moneycontrol.com Friday , November 16, 2012
EXECUTIVE BRIEFING
Pharmaceuticals
NEWS | markets | mutual funds | portfolio | VIDEO | wealth | messages
 
moneycontrol offers you a choice of various
sectoral & other newsletters for FREE!
Subscribe Now >>
 
Wockhardt Q2 profit surges over three-fold to Rs 454 cr
Drug firm Wockhardt today said its consolidated net profit surged over three-fold to Rs 453.55 crore for the second quar
Q2 earnings drive Suven Life to new 52-week high
Suven Life Sciences was up as much as 4.4 percent to hi...
Taro postpones shareholders meet on Sun Pharma merger
Israeli firm Taro Pharmaceutical Industries Ltd today s...
Orchid Chem to exit 50:50 manufacturing JV in China
Orchid Chemicals and Pharmaceuticals will exit 50:50 ma...
Abbott India Q2 PAT down 12% at Rs 38.3cr
Abbott India has announced its second quarter results. ...
Sterling Biotech Q3 net loss at Rs 76.67cr
Sterling Biotech has announced its third quarter result...
Biocon in pact with Bristol-Myers for 'blockbuster' drug
Biotech major Biocon has signed an option agreement wit...
Elder Pharma's Q2 profit jumps 22% to Rs 24 crore
Elder Pharma today said its consolidated net profit ros...
Dr Reddy's expects to launch open offer for OctoPlus in Dec
Drug firm Dr Reddy's Laboratories today said it expects...
>> More
>> Check out our other sectoral mailers
 
BSE Health
 
TOP COMPANIES IN THIS SECTOR
Company Last % Price Weekly Gain
Sun Pharma 679.10 -2.22
Cipla 380.10 -3.41
Dr Reddys Labs 1757.35 -0.62
Lupin 575.15 -1.41
Ranbaxy Labs 521.35 -3.85
Wockhardt 1738.95 6.7
GlaxoSmithKline 1988.55 -0.41
Cadila Health 819.95 -3.04
Divis Labs 1168.85 0.11
 
Events calendar
Book Closures ››more
24-Dec Ankur Drugs
 
STOCK RECOMMENDATION
Stock Advice Broker Reports
08:37 Aashish Tater bullish on pharma sectors for long-term
09:58 Cipla has target of Rs 730: Aashish Tater
09:48 Expect 50% returns in Glenmark Pharma: Tater
more  
03:32 Buy Wockhardt; target of Rs 2160: Emkay
12:54 Accumulate Cadila Healthcare; target Rs 930: Dolat Capital
04:52 Buy Sun Pharma; target of Rs 800: Emkay
more  
 
Follow us on:   Facebook   Twitter
Change Your Email Address | Unsubscribe | Subscribe | Terms of Service | Privacy Policy
 
Please add executive@briefing.moneycontrol.com to your address book to ensure delivery of our emails to your in-box.